Loading chat...

NJ A6008

Bill

Status

Introduced

11/17/2025

Primary Sponsor

Dawn Fantasia

Click for details

Origin

General Assembly

2024-2025 Regular Session

AI Summary

  • Expands the types of epinephrine delivery devices allowed in New Jersey schools from only pre-filled auto-injectors to any FDA-approved epinephrine administration mechanism

  • Requires public and nonpublic schools to maintain a supply of FDA-approved epinephrine administration devices in secure but unlocked, easily accessible locations for emergency use during anaphylactic reactions

  • School nurses and trained designees may administer epinephrine using any FDA-approved device to students experiencing anaphylaxis, including students without a known history of severe allergic reactions

  • Parents must provide written authorization and physician orders, and must sign liability waivers acknowledging they will indemnify schools for any injury arising from epinephrine administration

  • Permission for epinephrine administration must be renewed annually for each school year

Legislative Description

Expands epinephrine administration mechanisms permitted in schools.

Health

Last Action

Introduced, Referred to Assembly Health Committee

11/17/2025

Committee Referrals

Health11/17/2025

Full Bill Text

No bill text available